Bank of Montreal Can Has $52.10 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Bank of Montreal Can lifted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 365.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 711,487 shares of the company’s stock after purchasing an additional 558,689 shares during the quarter. Bank of Montreal Can owned 0.57% of Henry Schein worth $52,095,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of HSIC. California State Teachers Retirement System raised its holdings in Henry Schein by 1.7% during the 1st quarter. California State Teachers Retirement System now owns 212,108 shares of the company’s stock worth $16,018,000 after buying an additional 3,534 shares during the period. Tidal Investments LLC lifted its position in Henry Schein by 21.4% in the 1st quarter. Tidal Investments LLC now owns 5,632 shares of the company’s stock valued at $425,000 after acquiring an additional 994 shares in the last quarter. Wahed Invest LLC boosted its stake in Henry Schein by 14.3% in the 1st quarter. Wahed Invest LLC now owns 2,540 shares of the company’s stock worth $192,000 after purchasing an additional 318 shares during the period. DNB Asset Management AS increased its holdings in Henry Schein by 18.5% during the 2nd quarter. DNB Asset Management AS now owns 26,731 shares of the company’s stock worth $1,713,000 after purchasing an additional 4,176 shares in the last quarter. Finally, Beach Investment Counsel Inc. PA acquired a new stake in shares of Henry Schein in the 2nd quarter valued at about $37,000. Institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Stock Up 0.5 %

Henry Schein stock opened at $77.66 on Thursday. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The firm has a market capitalization of $9.68 billion, a PE ratio of 31.96, a P/E/G ratio of 2.20 and a beta of 0.87. The company’s 50-day moving average is $71.15 and its 200-day moving average is $69.78. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the prior year, the company earned $1.32 earnings per share. The business’s revenue for the quarter was up .4% compared to the same quarter last year. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have recently weighed in on HSIC. Evercore ISI increased their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. UBS Group decreased their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Robert W. Baird cut their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, JPMorgan Chase & Co. cut their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Six investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and a consensus target price of $79.38.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.